AZ closes $400 million Atacand sale to Germany’s CheplapharmAstraZeneca has completed the sell-off of another mature product, hiving off its Atacand cardiovascular franchise to Cheplapharm as Share XAZ closes $400 million Atacand sale to Germany’s Cheplapharmhttps://pharmaphorum.com/news/az-closes-400-million-atacand-sale-to-germanys-cheplapharm/
Out with the old… AZ sells European rights to AtacandAstraZeneca is selling off European commercial rights to its high blood pressure drug Atacand to German biotech Cheplapharm, Share XOut with the old… AZ sells European rights to Atacandhttps://pharmaphorum.com/news/out-with-the-old-az-sells-european-rights-to-atacand/
